ENG(Endoglin precursor) Market Report

Global and Region ENG(Endoglin precursor) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：215
  • REPORT CODE：GMM914491
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of ENG(Endoglin precursor) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of ENG(Endoglin precursor)market, defines the market attractiveness level of ENG(Endoglin precursor) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of ENG(Endoglin precursor) industry, describes the types of ENG(Endoglin precursor) market, the applications of major players and the market size, and deeply analyzes the current situation of the global ENG(Endoglin precursor) market and the development prospects and opportunities of ENG(Endoglin precursor) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global ENG(Endoglin precursor) market in Chapter 13.

    By Player:

    • Epigentek(US)

    • Aviva Systems Biology Corporation(USA)

    • Biosensis(US)

    • St John's Laboratory Ltd(UK)

    • Bioss Antibodies(US)

    • Rockland(US)

    • Novus Biologicals(US)

    • Abiocode(US)

    • Atlas Antibodies(Sweden)

    • Bio-Rad(US)

    • ProteoGenix(France)

    • Thermo Fisher Scientific(US)

    • BethylLaboratories(US)

    • Boster Biological Technology(USA)

    • BioVision(US)

    • USBiological(US)

    • Stemcell(Canada)

    • Genetex(US)

    • Lifespan Biosciences(US)

    • R&D Systems(US)

    • Abbexa Ltd(UK)

    • Biobyt(UK)

    • BioLegend(US)

    • Proteintech(US)

    • EnzoLifeSciences(Switzerland)

    • ProSci(US)

    By Type:

    • Above 90%

    • Above 95%

    • Above 99%

    • Others

    By End-User:

    • Biopharmaceutical Companies

    • Hospitals

    • Bioscience Research Institutions

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 ENG(Endoglin precursor) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 ENG(Endoglin precursor) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 ENG(Endoglin precursor) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 ENG(Endoglin precursor) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise ENG(Endoglin precursor) Market Analysis and Outlook to 2022

    • 7.1 Global ENG(Endoglin precursor) Consumption (2017-2022)

    • 7.2 United States ENG(Endoglin precursor) Consumption (2017-2022)

    • 7.3 Europe ENG(Endoglin precursor) Consumption (2017-2022)

    • 7.4 China ENG(Endoglin precursor) Consumption (2017-2022)

    • 7.5 Japan ENG(Endoglin precursor) Consumption (2017-2022)

    • 7.6 India ENG(Endoglin precursor) Consumption (2017-2022)

    • 7.7 South Korea ENG(Endoglin precursor) Consumption (2017-2022)

    8 Region and Country-wise ENG(Endoglin precursor) Market Analysis and Outlook to 2028

    • 8.1 Global ENG(Endoglin precursor) Consumption Forecast (2022-2028)

    • 8.2 United States ENG(Endoglin precursor) Consumption Forecast (2022-2028)

    • 8.3 Europe ENG(Endoglin precursor) Consumption Forecast (2022-2028)

    • 8.4 China ENG(Endoglin precursor) Consumption Forecast (2022-2028)

    • 8.5 Japan ENG(Endoglin precursor) Consumption Forecast (2022-2028)

    • 8.6 India ENG(Endoglin precursor) Consumption Forecast (2022-2028)

    • 8.7 South Korea ENG(Endoglin precursor) Consumption Forecast (2022-2028)

    9 Global ENG(Endoglin precursor) Market Outlook by Types and Applications to 2022

    • 9.1 Global ENG(Endoglin precursor) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Above 90% Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Above 95% Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Above 99% Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global ENG(Endoglin precursor) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Biopharmaceutical Companies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Bioscience Research Institutions Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global ENG(Endoglin precursor) Market Outlook by Types and Applications to 2028

    • 10.1 Global ENG(Endoglin precursor) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Above 90% Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Above 95% Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Above 99% Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global ENG(Endoglin precursor) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Biopharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Bioscience Research Institutions Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global ENG(Endoglin precursor) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global ENG(Endoglin precursor) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global ENG(Endoglin precursor) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 ENG(Endoglin precursor) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global ENG(Endoglin precursor) Market Competitive Analysis

    • 14.1 Epigentek(US)

      • 14.1.1 Epigentek(US) Company Details

      • 14.1.2 Epigentek(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Epigentek(US) ENG(Endoglin precursor) Product and Service

    • 14.2 Aviva Systems Biology Corporation(USA)

      • 14.2.1 Aviva Systems Biology Corporation(USA) Company Details

      • 14.2.2 Aviva Systems Biology Corporation(USA) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Aviva Systems Biology Corporation(USA) ENG(Endoglin precursor) Product and Service

    • 14.3 Biosensis(US)

      • 14.3.1 Biosensis(US) Company Details

      • 14.3.2 Biosensis(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Biosensis(US) ENG(Endoglin precursor) Product and Service

    • 14.4 St John's Laboratory Ltd(UK)

      • 14.4.1 St John's Laboratory Ltd(UK) Company Details

      • 14.4.2 St John's Laboratory Ltd(UK) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 St John's Laboratory Ltd(UK) ENG(Endoglin precursor) Product and Service

    • 14.5 Bioss Antibodies(US)

      • 14.5.1 Bioss Antibodies(US) Company Details

      • 14.5.2 Bioss Antibodies(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Bioss Antibodies(US) ENG(Endoglin precursor) Product and Service

    • 14.6 Rockland(US)

      • 14.6.1 Rockland(US) Company Details

      • 14.6.2 Rockland(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Rockland(US) ENG(Endoglin precursor) Product and Service

    • 14.7 Novus Biologicals(US)

      • 14.7.1 Novus Biologicals(US) Company Details

      • 14.7.2 Novus Biologicals(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Novus Biologicals(US) ENG(Endoglin precursor) Product and Service

    • 14.8 Abiocode(US)

      • 14.8.1 Abiocode(US) Company Details

      • 14.8.2 Abiocode(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Abiocode(US) ENG(Endoglin precursor) Product and Service

    • 14.9 Atlas Antibodies(Sweden)

      • 14.9.1 Atlas Antibodies(Sweden) Company Details

      • 14.9.2 Atlas Antibodies(Sweden) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Atlas Antibodies(Sweden) ENG(Endoglin precursor) Product and Service

    • 14.10 Bio-Rad(US)

      • 14.10.1 Bio-Rad(US) Company Details

      • 14.10.2 Bio-Rad(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Bio-Rad(US) ENG(Endoglin precursor) Product and Service

    • 14.11 ProteoGenix(France)

      • 14.11.1 ProteoGenix(France) Company Details

      • 14.11.2 ProteoGenix(France) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 ProteoGenix(France) ENG(Endoglin precursor) Product and Service

    • 14.12 Thermo Fisher Scientific(US)

      • 14.12.1 Thermo Fisher Scientific(US) Company Details

      • 14.12.2 Thermo Fisher Scientific(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Thermo Fisher Scientific(US) ENG(Endoglin precursor) Product and Service

    • 14.13 BethylLaboratories(US)

      • 14.13.1 BethylLaboratories(US) Company Details

      • 14.13.2 BethylLaboratories(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 BethylLaboratories(US) ENG(Endoglin precursor) Product and Service

    • 14.14 Boster Biological Technology(USA)

      • 14.14.1 Boster Biological Technology(USA) Company Details

      • 14.14.2 Boster Biological Technology(USA) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Boster Biological Technology(USA) ENG(Endoglin precursor) Product and Service

    • 14.15 BioVision(US)

      • 14.15.1 BioVision(US) Company Details

      • 14.15.2 BioVision(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 BioVision(US) ENG(Endoglin precursor) Product and Service

    • 14.16 USBiological(US)

      • 14.16.1 USBiological(US) Company Details

      • 14.16.2 USBiological(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 USBiological(US) ENG(Endoglin precursor) Product and Service

    • 14.17 Stemcell(Canada)

      • 14.17.1 Stemcell(Canada) Company Details

      • 14.17.2 Stemcell(Canada) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Stemcell(Canada) ENG(Endoglin precursor) Product and Service

    • 14.18 Genetex(US)

      • 14.18.1 Genetex(US) Company Details

      • 14.18.2 Genetex(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Genetex(US) ENG(Endoglin precursor) Product and Service

    • 14.19 Lifespan Biosciences(US)

      • 14.19.1 Lifespan Biosciences(US) Company Details

      • 14.19.2 Lifespan Biosciences(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 Lifespan Biosciences(US) ENG(Endoglin precursor) Product and Service

    • 14.20 R&D Systems(US)

      • 14.20.1 R&D Systems(US) Company Details

      • 14.20.2 R&D Systems(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 R&D Systems(US) ENG(Endoglin precursor) Product and Service

    • 14.21 Abbexa Ltd(UK)

      • 14.21.1 Abbexa Ltd(UK) Company Details

      • 14.21.2 Abbexa Ltd(UK) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 Abbexa Ltd(UK) ENG(Endoglin precursor) Product and Service

    • 14.22 Biobyt(UK)

      • 14.22.1 Biobyt(UK) Company Details

      • 14.22.2 Biobyt(UK) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.22.3 Biobyt(UK) ENG(Endoglin precursor) Product and Service

    • 14.23 BioLegend(US)

      • 14.23.1 BioLegend(US) Company Details

      • 14.23.2 BioLegend(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.23.3 BioLegend(US) ENG(Endoglin precursor) Product and Service

    • 14.24 Proteintech(US)

      • 14.24.1 Proteintech(US) Company Details

      • 14.24.2 Proteintech(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.24.3 Proteintech(US) ENG(Endoglin precursor) Product and Service

    • 14.25 EnzoLifeSciences(Switzerland)

      • 14.25.1 EnzoLifeSciences(Switzerland) Company Details

      • 14.25.2 EnzoLifeSciences(Switzerland) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.25.3 EnzoLifeSciences(Switzerland) ENG(Endoglin precursor) Product and Service

    • 14.26 ProSci(US)

      • 14.26.1 ProSci(US) Company Details

      • 14.26.2 ProSci(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.26.3 ProSci(US) ENG(Endoglin precursor) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of ENG(Endoglin precursor)

    • Figure ENG(Endoglin precursor) Picture

    • Table Global ENG(Endoglin precursor) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global ENG(Endoglin precursor) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global ENG(Endoglin precursor) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global ENG(Endoglin precursor) Consumption by Country (2017-2022)

    • Figure United States ENG(Endoglin precursor) Consumption and Growth Rate (2017-2022)

    • Table Europe ENG(Endoglin precursor) Consumption and Growth Rate (2017-2022)

    • Figure China ENG(Endoglin precursor) Consumption and Growth Rate (2017-2022)

    • Figure Japan ENG(Endoglin precursor) Consumption and Growth Rate (2017-2022)

    • Figure India ENG(Endoglin precursor) Consumption and Growth Rate (2017-2022)

    • Figure South Korea ENG(Endoglin precursor) Consumption and Growth Rate (2017-2022)

    • Figure Global ENG(Endoglin precursor) Consumption Forecast by Country (2022-2028)

    • Figure United States ENG(Endoglin precursor) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe ENG(Endoglin precursor) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China ENG(Endoglin precursor) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan ENG(Endoglin precursor) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India ENG(Endoglin precursor) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea ENG(Endoglin precursor) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Above 90% Consumption and Growth Rate (2017-2022)

    • Figure Global Above 95% Consumption and Growth Rate (2017-2022)

    • Figure Global Above 99% Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Biopharmaceutical Companies Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Bioscience Research Institutions Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Above 90% Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Above 95% Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Above 99% Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biopharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Bioscience Research Institutions Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global ENG(Endoglin precursor) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global ENG(Endoglin precursor) Export by Region (Top 5 Countries) (2017-2028)

    • Table Epigentek(US) (Foundation Year, Company Profile and etc.)

    • Table Epigentek(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Epigentek(US) ENG(Endoglin precursor) Product and Service

    • Table Aviva Systems Biology Corporation(USA) (Foundation Year, Company Profile and etc.)

    • Table Aviva Systems Biology Corporation(USA) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aviva Systems Biology Corporation(USA) ENG(Endoglin precursor) Product and Service

    • Table Biosensis(US) (Foundation Year, Company Profile and etc.)

    • Table Biosensis(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biosensis(US) ENG(Endoglin precursor) Product and Service

    • Table St John's Laboratory Ltd(UK) (Foundation Year, Company Profile and etc.)

    • Table St John's Laboratory Ltd(UK) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

    • Table St John's Laboratory Ltd(UK) ENG(Endoglin precursor) Product and Service

    • Table Bioss Antibodies(US) (Foundation Year, Company Profile and etc.)

    • Table Bioss Antibodies(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bioss Antibodies(US) ENG(Endoglin precursor) Product and Service

    • Table Rockland(US) (Foundation Year, Company Profile and etc.)

    • Table Rockland(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Rockland(US) ENG(Endoglin precursor) Product and Service

    • Table Novus Biologicals(US) (Foundation Year, Company Profile and etc.)

    • Table Novus Biologicals(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novus Biologicals(US) ENG(Endoglin precursor) Product and Service

    • Table Abiocode(US) (Foundation Year, Company Profile and etc.)

    • Table Abiocode(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abiocode(US) ENG(Endoglin precursor) Product and Service

    • Table Atlas Antibodies(Sweden) (Foundation Year, Company Profile and etc.)

    • Table Atlas Antibodies(Sweden) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Atlas Antibodies(Sweden) ENG(Endoglin precursor) Product and Service

    • Table Bio-Rad(US) (Foundation Year, Company Profile and etc.)

    • Table Bio-Rad(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bio-Rad(US) ENG(Endoglin precursor) Product and Service

    • Table ProteoGenix(France) (Foundation Year, Company Profile and etc.)

    • Table ProteoGenix(France) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

    • Table ProteoGenix(France) ENG(Endoglin precursor) Product and Service

    • Table Thermo Fisher Scientific(US) (Foundation Year, Company Profile and etc.)

    • Table Thermo Fisher Scientific(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Scientific(US) ENG(Endoglin precursor) Product and Service

    • Table BethylLaboratories(US) (Foundation Year, Company Profile and etc.)

    • Table BethylLaboratories(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

    • Table BethylLaboratories(US) ENG(Endoglin precursor) Product and Service

    • Table Boster Biological Technology(USA) (Foundation Year, Company Profile and etc.)

    • Table Boster Biological Technology(USA) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boster Biological Technology(USA) ENG(Endoglin precursor) Product and Service

    • Table BioVision(US) (Foundation Year, Company Profile and etc.)

    • Table BioVision(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioVision(US) ENG(Endoglin precursor) Product and Service

    • Table USBiological(US) (Foundation Year, Company Profile and etc.)

    • Table USBiological(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

    • Table USBiological(US) ENG(Endoglin precursor) Product and Service

    • Table Stemcell(Canada) (Foundation Year, Company Profile and etc.)

    • Table Stemcell(Canada) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Stemcell(Canada) ENG(Endoglin precursor) Product and Service

    • Table Genetex(US) (Foundation Year, Company Profile and etc.)

    • Table Genetex(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genetex(US) ENG(Endoglin precursor) Product and Service

    • Table Lifespan Biosciences(US) (Foundation Year, Company Profile and etc.)

    • Table Lifespan Biosciences(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lifespan Biosciences(US) ENG(Endoglin precursor) Product and Service

    • Table R&D Systems(US) (Foundation Year, Company Profile and etc.)

    • Table R&D Systems(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

    • Table R&D Systems(US) ENG(Endoglin precursor) Product and Service

    • Table Abbexa Ltd(UK) (Foundation Year, Company Profile and etc.)

    • Table Abbexa Ltd(UK) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbexa Ltd(UK) ENG(Endoglin precursor) Product and Service

    • Table Biobyt(UK) (Foundation Year, Company Profile and etc.)

    • Table Biobyt(UK) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biobyt(UK) ENG(Endoglin precursor) Product and Service

    • Table BioLegend(US) (Foundation Year, Company Profile and etc.)

    • Table BioLegend(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioLegend(US) ENG(Endoglin precursor) Product and Service

    • Table Proteintech(US) (Foundation Year, Company Profile and etc.)

    • Table Proteintech(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Proteintech(US) ENG(Endoglin precursor) Product and Service

    • Table EnzoLifeSciences(Switzerland) (Foundation Year, Company Profile and etc.)

    • Table EnzoLifeSciences(Switzerland) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

    • Table EnzoLifeSciences(Switzerland) ENG(Endoglin precursor) Product and Service

    • Table ProSci(US) (Foundation Year, Company Profile and etc.)

    • Table ProSci(US) ENG(Endoglin precursor) Sales, Price, Value and Gross Profit (2017-2022)

    • Table ProSci(US) ENG(Endoglin precursor) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US